You are here

Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
CHU Strasbourg
Strasbourg, Cedex, 67091 France
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Complete Remission in Renal Cell Carcinoma
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-99 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients with metastatic renal cell carcinoma, histopathologically confirmed

- Treated with sunitinib according to Smpc

- For cases: Achieving a CR (local assessment according to RECIST V1.0 criteria) with
Sunitinib in prior 6 months alone OR in combination with local treatment (surgery,
radiation therapy, ablative techniques: cryotherapy, RFA)

- For controls: Life expectancy > 3 months No prior Sunitinib treatment

- Patient >18 years

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Sunitinib administered in a non-approved label

- For cases: CR occurring without sunitinib treatment

- For controls: Prior systemic treatment

NCT01934452
Pfizer
Recruiting
Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Complete Remission in Renal Cell Carcinoma
NCT01934452
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now